Evidence map›Paper›PMID 19636535›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2009

Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips.

A Trifilieff, F Baur, J R Fozard

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Regulation of mast cell responses in health and disease.Critical reviews in immunology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

A TrifilieffNovartis Institutes for BioMedical Research, Respiratory Diseases Area, Novartis AG, 4002 Basel, Switzerland. alexandre.trifilieff@novartis.com
F Baur
J R Fozard
Novartis Institutes for BioMedical ResearchBoehringer Ingelheim (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung parenchymal strips isolated from ovalbumin-sensitized rats manifest a mast cell-dependent, biphasic contraction when challenged with allergen. The first phase is mediated by the release of preformed 5-HT while the second phase is dependent on de novo synthesis of leukotrienes. Sphingosine 1-phosphate (S1P) is a sphingolipid metabolite which is readily generated in mast cells and has been demonstrated to be an important regulator of allergen-induced mast cell activation. We have used the parenchymal strip to explore the role of sphingosine 1-phosphate and the S1P(2) receptor in the two components of the acute response to allergen. Lung parenchymal strips were prepared from Brown Norway rats actively sensitized to ovalbumin. The strips were set up in organ baths and contractile responses measured isometrically. The inhibitors of sphingosine kinase, D-erythro-NN-dimethylsphingosine (dimethylsphingosine) and 4-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-phenol (SKI-II) inhibited concentration-dependently both phases of the contractile response induced by 0.1 microg ml(-1) ovalbumin. The effects were seen at concentrations similar to those which inhibit the purified enzyme and were selective in that neither the contractile response to adenosine nor that to 5-hydroxytryptamine was affected. JTE-013 (a selective S1P(2) receptor antagonist) also blocked the response to ovalbumin (0.1 microg ml(-1)). However, the concentrations of JTE-013 required (microM) were substantially higher than its affinity for the S1P(2) receptors (nM). However, when tested against a lower concentration of ovalbumin (0.03 microg ml(-1)), JTE-013 inhibited the response with nM potency. These data demonstrate the importance of S1P and the S1P(2) receptor as regulators of allergen-induced activation of mast cells in their natural environment in the rat lung.

Indexed as

AcetatesAdenosineAllergensAnimalsBronchoconstrictionCyclopropanesDose-Response Relationship, DrugEnzyme InhibitorsInjections, SubcutaneousLeukotriene AntagonistsLungLysophospholipidsMaleMast CellsMethysergideOvalbumin4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenolAcetatesAdenosineAllergensCyclopropanesEnzyme InhibitorsJTE 013Leukotriene AntagonistsLysophospholipidsMethysergidemontelukastN,N-dimethylsphingosineOvalbuminPhosphotransferases (Alcohol Group Acceptor)PyrazolesPyridinesQuinolinesReceptors, LysosphingolipidSerotoninSerotonin AntagonistsSphingosinesphingosine 1-phosphateSphingosine KinaseSulfidesThiazoles

Identifiers

PMID19636535
OpenAlexW1974366894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.